Filing Details
- Accession Number:
- 0001209191-11-062910
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-22 19:00:53
- Reporting Period:
- 2011-12-20
- Filing Date:
- 2011-12-22
- Accepted Time:
- 2011-12-22 19:00:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401923 | Map Pharmaceuticals Inc. | MAPP | Pharmaceutical Preparations (2834) | 200507047 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1244229 | S Timothy Nelson | C/O Map Pharmaceuticals, Inc. 2400 Bayshore Parkway, Suite 200 Mountain View CA 94043 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-12-20 | 13,362 | $0.64 | 44,630 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-20 | 13,362 | $14.50 | 31,268 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-12-21 | 6,638 | $0.64 | 37,906 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-21 | 6,638 | $14.52 | 31,268 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-12-20 | 13,362 | $0.00 | 13,362 | $0.64 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-12-21 | 6,638 | $0.00 | 6,638 | $0.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 219,187 | 2015-05-09 | No | 4 | M | Direct | |
| 212,549 | 2015-05-09 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to a 10b5-1 trading plan in effect at the time of the transactions.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $14.50 to $14.56 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a security holder of the issuer.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $14.50 to $14.59 per share. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, or a security holder of the issuer.
- Fully exercisable.
Billionaire Hedge Funds
